Endonovo Therapeutics, Inc. (ENDV): Total Assets
Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$1.28M
As of 2022-12-31
-26.9%
3-year compound annual growth
-22.6%
5-year compound annual growth
+32.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $1.28M | -36.2% | 2023-04-17, Balance as of period end |
| 2021-12-31 | $2.01M | -23.0% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $2.61M | -20.4% | 2022-04-14, Balance as of period end |
| 2019-12-31 | $3.27M | -22.8% | 2021-04-13, Balance as of period end |
| 2018-12-31 | $4.24M | -8.0% | 2020-05-04, Balance as of period end |
| 2017-12-31 | $4.61M | n/m | 2019-04-15, Balance as of period end |
| 2016-12-31 | $318.7K | -22.2% | 2018-04-06, Balance as of period end |
| 2015-12-31 | $409.4K | +797.9% | 2017-04-17, Balance as of period end |
| 2014-12-31 | $45.6K | -38.1% | 2016-05-17, Balance as of period end |
| 2013-12-31 | $73.6K | -5.8% | 2015-06-15, Balance as of period end |
| 2012-12-31 | $78.1K | -92.1% | 2013-05-03, Balance as of period end |
| 2011-12-31 | $993.6K | +491.6% | 2013-05-03, Balance as of period end |
| 2010-12-31 | $167.9K | n/a | 2012-04-13, Balance as of period end |